These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36449983)

  • 1. What acute cardiac care physicians need to know from the latest 2022 ESC Guidelines for ventricular tachycardia and sudden cardiac death.
    Goette A; Lip GYH; Gorenek B
    Eur Heart J Acute Cardiovasc Care; 2023 Jan; 12(1):62-68. PubMed ID: 36449983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new ESC guidelines on the management of ventricular tachyarrhythmias : Implications for daily practice].
    Könemann H; Frommeyer G; Zeppenfeld K; Eckardt L
    Herz; 2023 Feb; 48(1):3-14. PubMed ID: 36441174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Updated ESC guideline: innovations for the treatment of ventricular arrhythmias and recommendations for prevention of sudden cardiac death].
    Eckardt L; Deneke T
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):288-94. PubMed ID: 27581243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ESC guidelines 2015 for ventricular arrhythmias and prevention of sudden cardiac death. What is new?].
    Fink T; Kuck KH; Metzner A;
    Herz; 2015 Dec; 40(8):1034-42. PubMed ID: 26626552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From premature ventricular complexes to sustained ventricular tachycardia : An overview of innovations in the 2022 ESC Guideline on the therapy of ventricular arrhythmias].
    Könemann H; Eckardt L
    Herzschrittmacherther Elektrophysiol; 2022 Dec; 33(4):450-457. PubMed ID: 36385401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk stratification for sudden cardiac death in post-infarct patients and in patients with dilated cardiomyopathy].
    Grimm W
    Z Kardiol; 2000; 89 Suppl 10():11-9; discussion 19-20. PubMed ID: 11151769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].
    van den Berg MP; van Tintelen JP; van Dessel PF; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2132-5. PubMed ID: 15553359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsustained ventricular tachycardia in dilated cardiomyopathy.
    Cuoco FA; Singh SN
    Curr Cardiol Rep; 2005 Sep; 7(5):368-75. PubMed ID: 16105493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
    Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
    Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ;
    Europace; 2015 Nov; 17(11):1601-87. PubMed ID: 26318695
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator.
    Nordenswan HK; Pöyhönen P; Lehtonen J; Ekström K; Uusitalo V; Niemelä M; Vihinen T; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Alatalo A; Pietilä-Effati P; Kupari M
    Circulation; 2022 Sep; 146(13):964-975. PubMed ID: 36000392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE-CMR.
    van der Lingen ACJ; Becker MAJ; Kemme MJB; Rijnierse MT; Spoormans EM; Timmer SAJ; van Rossum AC; van Halm VP; Germans T; Allaart CP
    J Am Heart Assoc; 2021 Apr; 10(8):e019101. PubMed ID: 33821672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
    Silka MJ; Kron J; Dunnigan A; Dick M
    Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of ventricular tachyarrhythmias and prevention of sudden cardiac death: commentary on the 2016 ESC guideline].
    Eckardt L; Köbe J; Wasmer K
    Dtsch Med Wochenschr; 2016 Aug; 141(16):1154-7. PubMed ID: 27509343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
    Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck KH; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ;
    Eur Heart J; 2015 Nov; 36(41):2793-2867. PubMed ID: 26320108
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive approach to management of ventricular arrhythmias.
    Kusumoto F
    Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.